Table 3 Clinical features of CT negativeand positive patients with COVID-19
From: Atypical presentations of coronavirus disease 2019 (COVID-19) from onset to readmission
Features | CT- negative (n=11) | CT-positive (n=68) | P-value |
|---|---|---|---|
Sex | 0.807a | ||
Male# | 6(54.5%) | 38(55.9%) | |
Female# | 5(45.5%) | 30(44.1%) | |
Age | 29.8±11.9 | 43.7±13.8 | 0.002b* |
Course of disease | 2.09±2.26 | 2.56±2.64 | 0.580b |
Clinical types | < 0.001c* | ||
Mild# | 11(100%) | 0(0.0%) | |
Moderate# | 0(0.0%) | 61(89.7%) | |
Severe# | 0(0.0%) | 7(10.3%) | |
Symptoms | 0.002a* | ||
Symptomatic# | 6(54.5%) | 63(92.6%) | |
Asymptomatic# | 5(45.5%) | 5(7.4%) | |
Re-detectable of RNA after discharged | 1.00a | ||
Negative# | 10(90.9%) | 62(91.2%) | |
Positive# | 1(9.1%) | 6(8.8%) | |
Hospitalization days | 12.6±6.01 | 16.6±6.74 | 0.065b |
Days of last RNA negative-conversion | 9.73±5.80 | 13.2±6.53 | 0.105b |
Days of last RNA negative-conversion category | 0.056c | ||
< 7 days# | 3(27.3%) | 7(10.3%) | |
7 days to 14 days# | 7(63.6%) | 36(52.9%) | |
14 days to 21 days# | 0(0.0%) | 22(32.4%) | |
> 21 days# | 1(9.1%) | 3(4.4%) | |
WBC count (×109/L) | 6.22±2.24 | 5.31±2.45 | 0.249b |
Lymphocyte count | 2.23±1.48 | 1.16±0.55 | 0.038b* |
Lymphocyte rate (%) | 33.5±13.2 | 23.8±10.5 | 0.008b* |
Neutrophil count(×109/L) | 3.59±1.82 | 3.64±2.30 | 0.955b |
Neutrophil rate (%) | 57.1±13.9 | 65.6±14.3 | 0.070b |